Granules India (GRANULES) Share Price Falls 2.44% as US FDA Inspection Begins at Gagillapur
- September 2, 2026
- Posted by: Kunal Singla
- Category: News
Granules India Share Price is trading at Rs 805.55, down 2.44% today, with the company valued at Rs 22,523.43 crore in market capitalisation. The move places Granules India Share Price in focus because it combines a clear price fall with a fresh regulatory update on the same day. As of 19 October 2026 at 3:23:11 PM IST, the stock had moved below the previous close of Rs 825.7 and was trading inside a narrow intraday band.The latest Granules India Share Price action therefore needs to be read alongside fundamentals, sector benchmarks and peer comparisons rather than through price alone. For readers tracking Granules India Share Price Today, the numbers show a lower trade, a Large Cap profile and a valuation that remains meaningful within pharmaceuticals.
Granules India (GRANULES) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 805.55 |
| Previous Close | Rs 825.7 |
| Today's Move | -Rs 20.15 (-2.44%) |
| Open | Rs 818.1 |
| High | Rs 836.3 |
| Low | Rs 802 |
| Market Capitalisation | Rs 22,523.43 crore |
| Market Cap Category | Large Cap |
Granules India Share Price Today reflects a Rs 20.15 decline from the previous close, with the stock last traded at Rs 805.55. The day opened at Rs 818.1, touched a high of Rs 836.3 and a low of Rs 802, showing a relatively contained range for the session so far. The market capitalisation stood at Rs 22,523.43 crore, and the company sits in the Large Cap category. In simple price terms, Granules India Share Price has stayed below the prior close throughout the visible trade, and the current level is near the day’s low rather than the opening print. That makes the Granules India Share Price movement important for intraday monitoring, especially for readers scanning Granules India Share Price Live updates, Granules India Share Price Update notes and Granules India Share Price Fall headlines. The next section looks at whether fundamentals provide context for this move.
Why Granules India (GRANULES) May Be Moving Today
Granules India (GRANULES) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 22,523.43 crore |
| P/E Ratio | 34.01x |
| P/B Ratio | 4.59x |
| ROE | 14.13% |
| ROCE | 15.74% |
| EPS | Rs 24.28 |
| Book Value Per Share | Rs 179.7 |
| Dividend Yield | 0.21% |
Granules India (GRANULES) fundamental metrics show P/E 34.01x, P/B 4.59x, ROE 14.13%, ROCE 15.74%. These ratios show where the company stands today and are not a call to buy or sell.
Granules India has a market capitalisation of Rs 22,523.43 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 34.01x, P/B at 4.59x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 14.13% and ROCE of 15.74%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 24.28, book value per share of Rs 179.7, dividend yield of 0.21%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.95x, median ROE of 10.96%, median ROCE of 13.01%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 34.01x |
| Benchmark Median P/E | 30.95x |
| Benchmark Average P/E | 46.82x |
| Benchmark P/E Range | 3.1x to 629.67x |
| Company P/B Ratio | 4.59x |
| Benchmark Median P/B | 2.82x |
| Benchmark Average P/B | 4.18x |
| Company ROE | 14.13% |
| Benchmark Median ROE | 10.96% |
| Benchmark Average ROE | 9.51% |
| Company ROCE | 15.74% |
| Benchmark Median ROCE | 13.01% |
| Benchmark Average ROCE | 12.48% |
| Company Market Capitalisation | Rs 22,523.43 crore |
| Benchmark Median Market Cap | Rs 720.23 crore |
| Benchmark Average Market Cap | Rs 13,282.41 crore |
Granules India (GRANULES) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Granules India (GRANULES) has a P/E ratio of 34.01x, which is above the benchmark median of 30.95x, a difference of +9.89%. A P/E difference of this kind is a reference point rather than a recommendation.
Granules India (GRANULES) has a ROE of 14.13%, which is above the benchmark median of 10.96%, a difference of +28.92%. Granules India (GRANULES) has a ROCE of 15.74%, which is above the benchmark median of 13.01%, a difference of +20.98%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,22,282.95 | 34.91 | 4.88 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,44,762.03 | 83.68 | 13.86 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,73,447.74 | 79.53 | 19.32 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,12,149.36 | 24.85 | 4.16 | 19.69 | 21.39 |
| Laurus Labs | LAURUSLABS | 1,11,250.29 | 101.75 | 19.73 | 18.31 | 18.2 |
Granules India (GRANULES) has a P/E ratio of 34.01x compared with the displayed peer median of 79.53x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 14.13% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 15.74% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Granules India (GRANULES) has a market capitalisation of Rs 22,523.43 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Granules India
- Granules India Share Price is trading lower by 2.44% today, keeping the stock in immediate price focus.
- The current Granules India Share Price of Rs 805.55 sits below the previous close of Rs 825.7.
- Granules India Share Price is being viewed alongside a US FDA inspection at the Gagillapur facility.
- The company’s P/E of 34.01 and P/B of 4.59 give Granules India Share Price a valuation context that is higher than the sector median.
- ROE of 14.13% and ROCE of 15.74% keep Granules India Share Price relevant within the pharmaceuticals peer group.
About Granules India
Granules India operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. The company is part of the Indian pharmaceutical manufacturing landscape and is tracked by investors for its business scale, profitability ratios and market position. Granules India Share Price therefore matters not only as a trading reference but also as a valuation marker for a Large Cap pharmaceutical company. The business context here is rooted in the company’s industry classification and the market’s ongoing assessment of its financial profile through earnings, book value and return ratios. For readers following Granules India Share Price, the company remains a part of the broader healthcare universe where operating metrics and regulatory updates can matter side by side.
Track Granules India Share Price on Univest
Use Granules India (GRANULES) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Investors can track Granules India Share Price on Univest for live share price updates, valuation ratios, market capitalisation, 52-week levels and market insights in one place. The platform also helps readers compare Granules India Stock News with sector benchmarks, peer metrics and company financials. If you are following Granules India Share Price Today, Univest brings the current trade context, fundamental analysis and sector comparison together without noise.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Granules India Share Price falling today?
Ans. Granules India Share Price is lower by 2.44% today and last traded at Rs 805.55. A US FDA inspection at the Gagillapur facility was reported on the same day, but the price data itself does not prove causation.
What is Granules India Share Price today?
Ans. Granules India Share Price is Rs 805.55, compared with the previous close of Rs 825.7. The stock opened at Rs 818.1 and moved between Rs 802 and Rs 836.3 during the visible trade so far.
How much did Granules India Share Price decline today?
Ans. Granules India Share Price declined by Rs 20.15, or 2.44%, from the previous close. The move keeps the stock in focus as a single-day price fall while still trading within a relatively narrow intraday range.
What is Granules India market capitalisation?
Ans. Granules India has a market capitalisation of Rs 22,523.43 crore. That places it in the Large Cap category and gives context to Granules India Share Price within the pharmaceutical universe and the broader healthcare sector.
What does Granules India P/E ratio show?
Ans. Granules India trades at a P/E ratio of 34.01. In the same industry benchmark, that is above the median of 30.95 and below the average of 46.82, which helps frame Granules India Share Price against peers.
What are Granules India ROE and ROCE?
Ans. Granules India reports ROE of 14.13% and ROCE of 15.74%. Both are above the sector medians in the same industry set, which gives Granules India Share Price a profitability context beyond the day’s decline.
How does Granules India compare with peers?
Ans. Granules India Share Price sits alongside peers such as Sun Pharma, Divi’s Laboratories, Torrent Pharmaceuticals and Zydus Lifesciences. Its market cap is smaller than several large pharma names, while its P/E and return ratios stay competitive.
What is Granules India book value and EPS?
Ans. Granules India book value is Rs 179.7 per share and EPS is Rs 24.28. Book value shows the accounting net worth behind each share, while EPS shows earnings attributable to each share for Granules India Share Price readers.
Should investors track Granules India Share Price on Univest?
Ans. Yes, investors tracking Granules India Share Price can use Univest for live price updates, market capitalisation, valuation ratios and sector context. It is useful for following Granules India Share Price Today alongside comparable pharmaceutical names.
